Secondary & Post-Hoc Analysis Manuscripts

$12,000

GPP3-compliant secondary publication development for subgroup, exploratory, and post-hoc analyses. Transparent reporting with appropriate statistical caveats. ICMJE authorship standards maintained.

SKU: EV-MC-002 Category:

Description

<![CDATA[

Secondary & Post-Hoc Analysis Manuscripts

GPP3-aligned secondary publication development for subgroup analyses, exploratory endpoints, and post-hoc investigations. Transparent communication of additional clinical trial insights.

Compliance Framework

  • GPP3 – Secondary publication guidance
  • ICMJE – Authorship and transparent reporting
  • CONSORT Extension – Harms, PROs, abstracts
  • STROBE – Observational component reporting

Analysis Types

  • Pre-specified subgroup analyses
  • Post-hoc exploratory analyses
  • Pooled/integrated efficacy analyses
  • Pooled safety analyses
  • Long-term extension data
  • Patient-reported outcome (PRO) analyses
  • Biomarker correlation studies
  • Health economic analyses

Transparency Requirements

  • Clear designation as post-hoc/exploratory
  • Multiplicity acknowledgment
  • Hypothesis-generating language
  • Primary publication cross-reference

Timeline

Standard: 8-12 weeks | Complexity dependent

]]>